Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
0.3600
+0.0300 (9.09%)
At close: Apr 1, 2025, 4:00 PM
0.3800
+0.0200 (5.56%)
After-hours: Apr 1, 2025, 4:18 PM EDT
CDIO Revenue
In the year 2024, Cardio Diagnostics Holdings had annual revenue of $34.89K with 104.45% growth. Cardio Diagnostics Holdings had revenue of $4.51K in the quarter ending December 31, 2024, a decrease of -15.03%.
Revenue (ttm)
$34.89K
Revenue Growth
+104.45%
P/S Ratio
254.43
Revenue / Employee
$2,326
Employees
15
Market Cap
18.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.89K | 17.83K | 104.45% |
Dec 31, 2023 | 17.07K | 16.12K | 1,696.32% |
Dec 31, 2022 | 950.00 | 49.00 | 5.44% |
Dec 31, 2021 | 901.00 | - | - |
Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CDIO News
- 6 days ago - Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session - Business Wire
- 2 months ago - Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations - Business Wire
- 3 months ago - Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire
- 5 months ago - Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference - Business Wire
- 6 months ago - Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests - Business Wire
- 8 months ago - Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions - Business Wire
- 9 months ago - Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois - Business Wire
- 10 months ago - Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum - Business Wire